Who's Not Sharing Their Clinical Trial Results?
Explore our data to see the universities, government bodies and pharmaceutical companies that fail to share their clinical trial results.
Send us a link
Explore our data to see the universities, government bodies and pharmaceutical companies that fail to share their clinical trial results.
When we pay for federally funded research, we should be allowed to read it. That’s the simple premise of FASTR, the Fair Access to Science and Technology Research Act.
A practical pathway to becoming an expert reviewer.
A court case may define the limits of anonymous scientific criticism
Women are still underrepresented in terms of authorships, including first and/or last authorships (whichever is more prestigious), coauthorships, and in the granting of scientific prizes.
How a corrosive culture keeps women out of leadership positions on math journals
An empirical analysis of researchers’ publications reveals that females have fewer distinct coauthors yet have a lower chance of repeating previous coauthors than their male counterparts.
Every state wants to be home to the next Google or Facebook. But it’s no coincidence that those companies are located in California. The latest data from the National Science Foundation (NSF) show that three of every 10 corporate research dollars are now spent in California.
An unbending reward system prevents early-career researchers taking full advantage of the digital world.
The U.S. depends on international collaborations and immigrants to solve domestic and global problems.
Erdogan, has taken direct control of the appointment of university rectors and a further 1,267 academics have been dismissed.
Reviewers who are experts in a given field are more likely to deliver harsher critiques of papers that hit close to home, researchers report.
Half of clinical trials do not have their results published. Those behind the TrialsTracker, a web tool created by the Evidence-Based Medicine Data Lab, at Oxford University, hope to change this.
Scientific research is being skewed by researchers and journals changing what they're looking for after the results of the study come in. But some people are finding ways to fight back against their own bias.
Tips from Nature Research editors.
More than 1000 academics fired.
Calculation suggests papers with women first-authors have citation rates pushed down by 10%.
Genome editor CRISPR could put mutant mice in everyone's reach
Papers are like “lottery tickets,” researchers conclude
Computerized search of trial registry lists worst offenders.
Science says career success is random. Here's what that looks like.
The University of Oregon is launching a new science campus, backed by a $500 million gift from Nike Inc. co-founder Phil Knight and his wife.
Tata Trusts and UC San Diego partner to establish Tata Institute for Active Genetics and Society.
A tool was produced that identifies all completed trials from clinicaltrials.gov, searches for results in the clinicaltrials.gov registry and on PubMed, and presents summary statistics for each sponsor online. Since Jan 2006, trial sponsors included in our dataset have completed 25,927 eligible trials, of which 11,714 (45.2%) have failed to make results available.
New equation also suggests way to predict a researcher's potential to produce top work.